Skip to main content

CITADEL ADVISORS LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1423053 MIAMI, FL

Position in TLRY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$89,984
-$1,287,894 QoQ
Shares Held
13,908
-90.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Mar 31, 2026
CallValue
$6,459,259
CallShares
998,340
PutValue
$3,945,017
PutShares
609,740

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $928,363,116 across 59 Drug Manufacturers - Specialty & Generic names. TLRY ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TLRY

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $89,984 13,908
2026-03-31 $6,459,259 998,340
2026-03-31 $3,945,017 609,740
2025-12-31 $11,729,789 1,298,980
2025-12-31 $14,293,045 1,582,840
2025-12-31 $1,377,878 152,589